An interventional study of Sealed washable floor plus behaviour change and Behaviour change intervention in Diarrhoeal Disease, Hookworm Infection and Ascaris Lumbricoides Infection, sponsored by London School of Hygiene and Tropical Medicine. Completed at 1 site in Kenya. Per ClinicalTrials.gov, last updated 2025-01-30.
Sponsored by London School of Hygiene and Tropical Medicine · Not applicable, Interventional, and Prevention
The goal of this intervention study is to learn about the impact of household flooring on health in rural Kenya, and test whether providing an improved (cement stabilised, washable) floor improves the health of children and their care providers.
The main questions the study aims to answer are:
The study will involve a trial, where half of the recruited households will be randomly chosen to receive the new floor in addition to some support on how to care for the floor and keep it clean. The other half of households will not receive anything at first, but at the end of the research project will also receive a new floor.
Before the new floors are installed, the investigators will make several assessments in all study households. These will include a survey to measure household characteristics; a stool survey, to measure how many people are infected with diarrhoea-causing microorganisms and parasitic worms; a jigger flea examination among children; wellbeing assessments among children and caregivers; and soil sampling to identify microorganisms on the floor of the household.
When households receive the new floor, participants will have to move out of their house for up to 7 days during installation. Participants will also be asked to attend some group meetings to discuss ways of taking care of the floor and keeping it clean.
Assessments will be repeated 12 months after the floor has been delivered, and additional interviews will be held with a small number of randomly selected participants. Throughout the 12 months following delivery of the intervention, investigators will make unannounced visits to households to check the condition of the floor. Participants will also be offered treatment for parasitic worm infections after assessments have been completed at the start and end of the project.
Earthen floors are often damp or dusty and difficult to clean, providing an ideal environment for faecal pathogens and parasites. Cross-sectional studies have revealed associations between household flooring and health outcomes, but robust experimental evidence is scant. This study will evaluate the impact of an improved household flooring intervention on enteric infections, soil-transmitted helminth (STH) infections, and tungiasis through implementation of a cluster-randomised trial in two rural settings in Kwale and Bungoma Counties, Kenya.
The primary aim of this study is to evaluate the effectiveness of an improved flooring intervention in reducing the burden of enteric infections, STH and tungiasis in participating households through implementation of a randomised controlled trial (RCT) in two distinct settings in rural Kenya. The primary objectives are to quantify impact on the prevalence of enteric infections, STH infections, and tungiasis. Secondary objectives include assessing impact on the wellbeing of caregivers and children, self-report gastrointestinal illness in children, and the extent to which entero-pathogen and parasitic contamination of floors is reduced within the home. We will also examine the differential effects across community and household contexts (including water, sanitation, and hygiene (WASH) infrastructure, animal husbandry, user adherence and study site). Lastly, we deliver a process evaluation to determine the practicality, acceptability, costs, and durability of the improved flooring intervention and how environmental, installation, and use factors affect these.
In total, 440 clusters (households) across both sites are allocated to either control or intervention group, in which a low-cost, sealed, washable cement-based floor is installed in all eligible buildings of the dwelling, alongside a floor care guide provided during an induction meeting. Prevalence of enteric infections in children under 5 years will be assessed via stool surveys and PCR; prevalence of tungiasis infection in children 1-14 years based on clinical exam; and prevalence of STH infection in all household members over 1 year assessed via Kato-Katz. Following the 12-month implementation period and final assessments, control households will be offered improved floors.
39 studies on the registry are indexed under Hookworm Infections; 5 are open to participants now.
This study's enrollment of 2,200 is above the median of 182 across 36 interventional studies indexed under Hookworm Infections.
Browse Hookworm Infections studies →London School of Hygiene and Tropical Medicine is the lead sponsor of 298 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
* Replacement of rudimentary floors with an improved floor, * Support for behaviour change through 'floor clubs'. * Annual mass treatment for STH infections (400 mg albendazole) * Treatment of tungiasis in those affected by heavy infections (at 0 and 12 months) according to county DoH recommendations
Other: Sealed washable floor plus behaviour change · Behavioral: Behaviour change intervention · Drug: Routine deworming · Procedure: treatment for tungiasis
* Annual mass treatment for STH infections (400 mg albendazole) * Treatment of tungiasis in those affected by heavy infections (at 0 and 12 months) according to county DoH recommendations
Drug: Routine deworming · Procedure: treatment for tungiasis
Replacement of rudimentary floors with a cement stabilised floor in all rooms in the dwelling
Support for behaviour change through 'floor clubs' and the provision of printed guides
Treatment of all household members for STH infections (400 mg albendazole in those aged 24 months and above; 200 mg albendazole in those aged 12-23 months)
Also known as: albendazole
Treatment of tungiasis in those affected by heavy infections (at 0 and 12 months) according to county Department of Health recommendations
Enteric infections
Prevalence of enteric infections (detected through PCR) in children under 5 years old will be assessed using cross-sectional stool surveys including all enrolled children under 5 years before installation of floors and 12 months after receiving the floors. Pathogens to be identified from those observed at baseline using a multipathogen panel on a subset of 100 samples.
Time frame: 12 months
Tungiasis infections
Prevalence of tungiasis (detected through clinical examination of hands and feet) in children under 15 years old will be assessed using cross-sectional clinical assessment surveys including all enrolled children under 15 years before installation of floors and 12 months after receiving the floors.
Time frame: 12 months
STH infections
Prevalence of at least one STH infection (hookworm, ascaris and trichuris infections; detected through kato katz) in all household members 12 months and older will be assessed using cross-sectional stool surveys including all enrolled people over 12 months of age before installation of floors and 12 months after receiving the floors.
Time frame: 12 months
Gastrointestinal illness
Prevalence of gastrointestinal illness in children under 5 years - assessed in both study arms based on caregiver reported symptoms
Time frame: 12 months
Intensity and severity of tungiasis
Intensity of tungiasis and severity of acute and chronic tungiasis-associated pathology in children \<15 years - assessed using clinical severity scores (range: 0-110, high scores indicating increased severity/worse outcome)
Time frame: 12 months
Quality of Life for children aged 8 to 14 years
Quality of Life assessed in children ages 8 to 14 years in both arms using the standardised EQ5D-Y (EuroQol 5-dimension health-related quality of life tool for children; values are anchored at 1 (full health) and 0 (a state as bad as being dead))
Time frame: 12 months
Quality of Life and subjective wellbeing in primary caregivers
Quality of Life assessed in primary caregivers in both arms using the standardised EQ5D tool (EuroQol 5-dimension health-related quality of life tool for adults; values are anchored at 1 (full health) and 0 (a state as bad as being dead))
Time frame: 12 months
Prevalence of Ascaris lumbricoides infection
Ascaris lumbricoides (roundworm) infection prevalence in all household members \>1 year assessed using Kato Katz
Time frame: 12 months
Prevalence of hookworm infection
Hookworm infection prevalence in all household members \>1 year assessed using Kato Katz
Time frame: 12 months
Prevalence of Trichuris trichiura infection
T. trichiura (whipworm) infection prevalence in all household members \>1 year assessed using Kato Katz
Time frame: 12 months
Environmental contamination - enteric pathogens
Environmental contamination for human-specific and animal faecal markers - assessed from dust/soil samples from household cooking areas and living rooms using PCR.
Time frame: 12 months
Environmental contamination - tungiasis
Contamination of floors with eggs, larvae, pupae and adults of T. penetrans - assessed through entomology soil surveys
Time frame: 6 months
Plan to share: Yes — Data collected from this study and underlying each article (text, tables, figures, and appendices), including quantitative, de-identified, individual participant data and a data dictionary, will be made available following publication of the article(s).
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report
Time frame: The quantitative, individual, de-identified, participant data that underlie the results reported in each published article (text, tables, figures, and appendices) will be made available within three months of publication of each article, with no end date.
Access criteria: The data will be made available to members of the scientific and medical community for non-commercial use only, upon email request to the corresponding author. Written proposals will be assessed by members of the SABABU Trial Group and a decision made about the appropriateness of the use of data. Data will be stored at LSHTM Data Compass, the London School of Hygiene \& Tropical Medicine digital data repository The data will be available to anyone who wishes to access the data through the LSHTM Data Compass, the London School of Hygiene \& Tropical Medicine digital data repository. URL is https://datacompass.lshtm.ac.uk/
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
London School of Hygiene and Tropical Medicine →